GS
Gilead Sciences Portfolio holdings
AUM
$1.28B
This Quarter Return
+14.14%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.28B
AUM Growth
+$98.9M
(+8.4%)
Cap. Flow
-$2.42M
Cap. Flow
% of AUM
-0.19%
Top 10 Holdings %
Top 10 Hldgs %
99.79%
Holding
14
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
IMA
ImageneBio, Inc. Common Stock
IMA
|
+$1.09M |
| 2 |
KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
|
+$1.08M |
| 3 |
BRNS
Barinthus Biotherapeutics
BRNS
|
+$251K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Galapagos
GLPG
$2.11B
| $468M | 36.53% |
16,707,477
| – | – |
|
2
Arcellx
ACLX
$4.23B
| $443M | 34.57% |
6,720,803
| – | – |
|
3
Arcus Biosciences
RCUS
$1.23B
| $256M | 19.98% |
31,424,760
| – | – |
|
4
Assembly Biosciences
ASMB
$173M
| $40M | 3.13% |
2,209,471
| – | – |
|
5
Tango Therapeutics
TNGX
$727M
| $24.9M | 1.94% |
4,854,443
| – | – |
|
6
Merus
MRUS
$5.26B
| $23.8M | 1.86% |
452,527
| – | – |
|
7
Kyverna Therapeutics
KYTX
$170M
| $12.7M | 0.99% |
4,126,119
| – | – |
|
8
Xilio Therapeutics
XLO
$38.2M
| $6.19M | 0.48% |
9,105,451
| – | – |
|
|
HOOK
9
DELISTED
HOOKIPA Pharma
HOOK
| $2.35M | 0.18% |
1,875,945
| – | – |
|
10
Leap Therapeutics
LPTX
$12.4M
| $1.58M | 0.12% |
5,319,148
| – | – |
|
11
Allogene Therapeutics
ALLO
$251M
| $1.31M | 0.1% |
1,156,689
| – | – |
|
|
KLRS
12
Kalaris Therapeutics, Inc. Common Stock
KLRS
$72.8M
| $848K | 0.07% |
317,789
-405,484
| -56% | -$1.08M |
|
|
IMA
13
ImageneBio, Inc. Common Stock
IMA
$102M
| $467K | 0.04% |
29,045
-67,550
| -70% | -$1.09M |
|
|
BRNS
14
Barinthus Biotherapeutics
BRNS
$44.8M
| $92.5K | 0.01% |
99,478
-270,377
| -73% | -$251K |
|